02 June 2026 : Clinical Research
Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial
Zhong Zhang ABC 1, Zhixu Wang BC 1, Wanwan Gong DEF 1, Wei Jiang AF 1*, Longjiao Zheng DEF 1, Zhiyang Yu AEF 1DOI: 10.12659/MSM.952468
Med Sci Monit 2026; 32:e952468
Table 2 Anesthetic dosage and sedation-related intervals.
| Variable | CK (n=60) | CR (n=60) | χ2/t | P |
|---|---|---|---|---|
| Ciprofol dose (mg) | ||||
| Induction | 23.1±3.7 | 24.0±2.4 | −1.559 | 0.122 |
| Maintenance | 32.4±16.1 | 31.0±14.6 | 0.499 | 0.619 |
| Total | 55.4±16.4 | 55.0±14.7 | 0.152 | 0.879 |
| Time | ||||
| Induction (s) | 55.1±3.9 | 56.1±3.0 | −1.465 | 0.145 |
| Operation (min) | 24.2±13.7 | 21.4±10.1 | 2.251 | 0.213 |
| Recovery (min) | 5.3±1.9 | 4.8±2.2 | 1.310 | 0.193 |
| CK – ciprofol-esketamine regimen; CR – ciprofol-remifentanil regimen. | ||||